Načítá se...
PDCT-04. SAFETY AND EFFICACY OF INTRAVENTRICULAR (131)I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE
BACKGROUND: Tumors metastasizing to the central nervous system (CNS) are associated with significant mortality. Intraventricular (131)I-labeled monoclonal antibody targeting tumor associated antigens may eradicate micrometastases. METHODS: We tested the toxicity and dosimetry of intraventricular (13...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693087/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.748 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|